Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
EPA May Require Testing For Roundup Herbicide Residue Due To Cancer Concerns April 21, 2015 Irvin Jackson Add Your Comments Federal regulators may soon require testing to see if residue from the active ingredient in Roundup weed killer is making its way into food. The possible testing comes following recent concerns that the herbicide may cause cancer. Officials with the Environmental Protection Agency (EPA) said the agency may require sampling to detect residue from glyphosate, the active ingredient in Roundup, in the future. A final determination would be based on information gathered from the U.S. Department of Agriculture’s Pesticide Data Program. In the agency’s last review, glyphosate was determined to be fairly safe. However, in March, the International Agency for Research on Cancer (IARC) labeled the weedkiller chemical a “probable carcinogen.” ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION IARC is the World Health Organization’s (WHO) cancer research division. The group released a report last month in the medical journal The Lancet Oncology, identifying five pesticides and herbicides as probably cancer-causing agents. The chemicals cited in the report include glyphosate, tetrachlorvinphos, parathion, malathion, and diazinon. The list was compiled by 17 experts from 11 different countries. The determination by IARC outraged officials at Monsanto, the makers of Roundup, the most popular herbicide in the world. Monsanto officials called IARC’s determination “junk science” that was conducted based on an anti-Monsanto agenda. The EPA has only previously tested for glyphosate in 2011, when it found 271 out of 300 soybean samples had glyphosate residue. However, all the tests indicated that the residue was below the EPA’s tolerance level of 20 parts per million. That tolerance level was set before the drug was declared a possible carcinogen. Concerns regarding the safety of Roundup prompted a special EPA meeting last year to discuss the safety of glyphosate. The EPA heard from scientists, environmentalists and concerned mothers regarding the potential side effects of Roundup to decide on whether to place further restriction on the chemical, a decision is expected this year. A study published by the U.S. Department of Agriculture (USDA) last year revealed pesticide residue is found in half of all food in the U.S. More than 8,500 samples of fruit, vegetables, infant formula, butter, salmon, groundwater and drinking water were tested for the study. Half contained detectable levels of pesticide residue, however 23 samples exceeded EPA safe tolerance limits. Weed killers are commonly detected in the air, food and water near areas that have been sprayed, according to the report. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Glyphosate, Herbicide, Monsanto, Roundup Image Credit: Image via <a href="http://www.shutterstock.com/gallery-57044p1.html?cr=00&pl=edit-00">Jeffrey B. Banke</a> / <a href="http://www.shutterstock.com/editorial?cr=00&pl=edit-00">Shutterstock.com</a> More Roundup Lawsuit Stories Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial July 25, 2025 New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (Posted: yesterday) Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries. MORE ABOUT: OZEMPIC LAWSUITJudge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (10/21/2025)Ozempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025) GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: 4 days ago) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025) Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 5 days ago) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)
Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (Posted: yesterday) Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries. MORE ABOUT: OZEMPIC LAWSUITJudge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (10/21/2025)Ozempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)
GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: 4 days ago) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025)
Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 5 days ago) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)